Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -79.60% | 53.77% | 44.41% | -172.84% | 55.49% |
| Total Depreciation and Amortization | -38.72% | 33.74% | -44.13% | 83.11% | 29.77% |
| Total Amortization of Deferred Charges | 396.58% | 67.09% | 107.21% | -310.62% | -33.05% |
| Total Other Non-Cash Items | 51.63% | -609.56% | -92.06% | 584.11% | -225.95% |
| Change in Net Operating Assets | 137.70% | 17.00% | -52.25% | -2,713.74% | 98.34% |
| Cash from Operations | 53.80% | -27.03% | -6.76% | -53.24% | 28.81% |
| Capital Expenditure | 72.04% | -27.40% | 70.92% | -50.30% | 63.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -53.77% |
| Cash from Investing | 72.04% | -27.40% | 70.92% | -74.31% | 64.77% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -16.36% | 28.38% | -56.52% | -35.29% | -13.33% |
| Issuance of Common Stock | -- | -- | -- | 1,198,957.14% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -245,700.00% | -- |
| Cash from Financing | -176.50% | 208.94% | -167.21% | 415.13% | -13.31% |
| Foreign Exchange rate Adjustments | 179.54% | -668.60% | 142.48% | -124.49% | 165.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,250.83% | 106.05% | -320.50% | 199.84% | 40.36% |